1. 1568. Implementation of a Standard Diet Regimen for Neutropenic High-Risk Cancer Patients: Effects on Incidence of Infections, Foodborne Diseases, and Outcome. (26th November 2018) Authors: Jakob, Carolin; Löhnert, Annika Y; Stecher, Melanie; Engert, Andreas; Freund, Meike; Hamprecht, Axel; Jazmati, Nathalie; Wisplinghoff, Hilmar; Hallek, Michael; Cornely, Oliver A; Vehreschild, Janne Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S489 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trial. (14th September 2021) Authors: Gerhard‐Hartmann, Elena; Goergen, Helen; Bröckelmann, Paul J.; Mottok, Anja; Steinmüller, Tabea; Grund, Johanna; Zamò, Alberto; Ben‐Neriah, Susana; Sasse, Stephanie; Borchmann, Sven; Fuchs, Michael; Borchmann, Peter; Reinke, Sarah; Engert, Andreas; Veldman, Johanna; Diepstra, Arjan; Klapper, Wolf... Journal: British journal of haematology Issue: Volume 196:Number 1(2022) Page Start: 116 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Affordability of Medicines a Top Priority for EHA: Toward a Fair Pricing Model for Innovative Medicines. Issue 1 (December 2017) Authors: Hagenbeek, Anton; Engert, Andreas; Kapitein, Peter; Doeswijk, Robin Journal: HemaSphere Issue: Volume 1:Issue 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AFM13 in patients with relapsed or refractory classical Hodgkin lymphoma: final results of an open-label, randomized, multicenter phase II trial. Issue 8 (3rd July 2022) Authors: Sasse, Stephanie; Bröckelmann, Paul Jan; Momotow, Jesko; Plütschow, Annette; Hüttmann, Andreas; Basara, Nadezda; Koenecke, Christian; Martin, Sonja; Bentz, Martin; Grosse-Thie, Christina; Thorspecken, Sven; de Wit, Maike; Kobe, Carsten; Dietlein, Markus; Tresckow, Bastian von; Fuchs, Michael; Bor... Journal: Leukemia & lymphoma Issue: Volume 63:Issue 8(2022) Page Start: 1871 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Anti-epidermal growth factor receptor antibody cetuximab in refractory or relapsed multiple myeloma: a phase II prospective clinical trial. Issue 3 (March 2014) Authors: von Tresckow, Bastian; Boell, Boris; Eichenauer, Dennis; Beschorner, Denissa; Knop, Stefan; Goebeler, Maria-Elisabeth; Chemnitz, Jens Marcus; Hallek, Michael; Engert, Andreas; Huebel, Kai Journal: Leukemia & lymphoma Issue: Volume 55:Issue 3(2014:Mar.) Page Start: 695 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Antibodies and antibody‐drug conjugates in the treatment of Hodgkin lymphoma. (9th May 2014) Authors: Eichenauer, Dennis A.; Engert, Andreas Journal: European journal of haematology Issue: Volume 93:Number 1(2014:Jul.) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Baseline serum TARC levels predict therapy outcome in patients with Hodgkin lymphoma. Issue 2 (8th December 2012) Authors: Sauer, Maike; Plütschow, Annette; Jachimowicz, Ron D.; Kleefisch, Dominik; Reiners, Katrin S.; Ponader, Sabine; Engert, Andreas; von Strandmann, Elke Pogge Journal: American journal of hematology Issue: Volume 88:Issue 2(2013:Feb.) Page Start: 113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Brentuximab vedotin (SGN-35) in patients with transplant-naive relapsed/refractory Hodgkin lymphoma. Issue 10 (October 2013) Authors: Sasse, Stephanie; Rothe, Achim; Goergen, Helen; Eichenauer, Dennis A.; Lohri, Andreas; Kreher, Stephan; Jäger, Ulrich; Bangard, Christopher; Kuhnert, Georg; Böll, Boris; von Tresckow, Bastian; Engert, Andreas Journal: Leukemia & lymphoma Issue: Volume 54:Issue 10(2013:Oct.) Page Start: 2144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study Group. Issue 10 (October 2016) Authors: Kreissl, Stefanie; Mueller, Horst; Goergen, Helen; Mayer, Axel; Brillant, Corinne; Behringer, Karolin; Halbsguth, Teresa Veronika; Hitz, Felicitas; Soekler, Martin; Shonukan, Oluwatoyin; Rueffer, Jens Ulrich; Flechtner, Hans-Henning; Fuchs, Michael; Diehl, Volker; Engert, Andreas; Borchmann, Peter Journal: Lancet oncology Issue: Volume 17:Issue 10(2016:Oct.) Page Start: 1453 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Clinical characteristics and outcomes of patients with Hodgkin lymphoma with central nervous system involvement: An international multicenter collaboration. Issue 9 (20th June 2016) Authors: Cheah, Chan Y.; Bröckelmann, Paul J.; Chihara, Dai; Moskowitz, Alison J.; Engert, Andreas; Jerkeman, Mats; El‐Galaly, Tarec C.; Augustson, Bradley; Vose, Julie; Bartlett, Nancy L.; Villa, Diego; Connors, Joseph M.; Feldman, Tatyana; Pinnix, Chelsea C.; Milgrom, Sarah A.; Dabaja, Bouthaina; Oki, Y... Journal: American journal of hematology Issue: Volume 91:Issue 9(2016:Sep.) Page Start: 894 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗